+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06599307

Rituximab Treatment to Improve Thinking and Hand Skills in Adults with Secondary Progressive Multiple Sclerosis

Led by Cairo University · Updated on 2026-03-18

46

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether rituximab can improve thinking skills and hand functions in people with secondary progressive multiple sclerosis SPMS who have significant disability EDSS score of 6.5 or higher. This phase 2 randomized controlled trial compares rituximab to a placebo to understand its effects on cognition, hand function, quality of life, and disability level as measured by the Expanded Disability Status Scale EDSS. Participants demographic and clinical information such as age, gender, disease duration, and EDSS scores will be collected. Participants will be randomly assigned to receive either rituximab or placebo infusions. The rituximab group will get an initial total dose of 1 gram divided into two 500 mg infusions two weeks apart, followed by another 1 gram infusion after six months, all given intravenously diluted in 500 ml of normal saline. The placebo group will receive 500 ml of normal saline infusions on the same schedule. The study lasts for one year with treatments and assessments throughout this period. During the study, participants will undergo tests including the Symbol Digit Modalities Test, Brief Visuospatial Memory Test-Revised, California Verbal Learning Test-II, and the Nine-Hole Peg Test to assess cognition and hand function. Quality of life and disability status using the EDSS will also be measured. These assessments will be done at baseline and after one year of treatment. The trial includes regular monitoring to evaluate the effects of rituximab and to ensure participant safety.

CONDITIONS

Brief Title

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

Research Team

A

Amgad Mahmoud Elmeligy, MSc Neurology

A

Amr Mohamed Fouad, MD Neurology

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here